Theodora Kanni (T Kanni)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Hidradenitis Suppurativa

Top Venues

Expert opinion on biological therapy

The British journal of dermatology

Clinical and experimental dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitra Stergianou, Theodora Kanni, Christina Damoulari, Evangelos J Giamarellos-Bourboulis
An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa. Expert opinion on biological therapy (2024)
Dimitra Stergianou, Theodora Kanni, Christina Damoulari, Evangelos J Giamarellos-Bourboulis
An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa. Expert opinion on biological therapy (2024)
Dimitra Stergianou, Theodora Kanni, Christina Damoulari, Evangelos J Giamarellos-Bourboulis
An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa. Expert opinion on biological therapy 24 (4) (2024)
Dimitra Stergianou, Theodora Kanni, Christina Damoulari, Evangelos J Giamarellos-Bourboulis
An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa. Expert opinion on biological therapy 24 (4) (2024)
Dimitra Stergianou, Theodora Kanni, Christina Damoulari, Evangelos J Giamarellos-Bourboulis
An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa. Expert opinion on biological therapy 24 (4) (2024)
Antonella Di Cesare, Georgios Nikolakis, Theodora Kanni, Evangelos J Giamarellos-Bourboulis, Łukasz Matusiak, Jacek Cezary Szepietowski, Christos C Zouboulis, Francesca Prignano
Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study. The British journal of dermatology 187 (3) (2022)
Evangelos J Giamarellos-Bourboulis, M Argyropoulou, Theodora Kanni, T Spyridopoulos, I Otto, O Zenker, R Guo, N C Riedemann
Clinical efficacy of complement C5a inhibition by IFX-1 in hidradenitis suppurativa: an open-label single-arm trial in patients not eligible for adalimumab. The British journal of dermatology 183 (1) (2020)
Theodora Kanni, M Argyropoulou, C A Dinarello, J Simard, Evangelos J Giamarellos-Bourboulis
MABp1 targeting interleukin-1α in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period. Clinical and experimental dermatology 46 (1) (2020)
Eleftheria Tampouratzi, Theodora Kanni, John Katsantonis, Theodora Douvali
Modified Mercedes flap - an effective reconstructive option for lower leg skin defects. The Journal of dermatological treatment 31 (6) (2019)
Eleftheria Tampouratzi, Theodora Kanni, John Katsantonis, Theodora Douvali
Case report: Treating a combination of hidradenitis suppurativa and psoriasis with different therapeutic approaches. F1000Research 8 (2019)
Eleftheria Tampouratzi, Theodora Kanni, John Katsantonis, Theodora Douvali
Case report: Treating a co-existence of hidradenitis suppurativa and psoriasis with different therapeutic approaches. F1000Research 8 (2019)